To test whether KD of Casz1 and/or Zfp961 could reduce atherosclerosis, we used a mouse atherosclerosis model, in which all adult mice were transduced with mutant mouse gain-of-function Pcsk9 (mPcsk9) (17). Here, PCSK9 is linked to atherosclerosis.